|
1
|
Nishida N, Murakami F and Higaki K:
Detection of serous precursor lesions in resected fallopian tubes
from patients with benign diseases and a relatively low risk for
ovarian cancer. Pathol Int. 66:337–342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeppernick F, Meinhold-Heerlein I and Shih
IeM: Precursors of ovarian cancer in the fallopian tube: Serous
tubal intraepithelial carcinoma - an update. J Obstet Gynaecol Res.
41:6–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen J, Shi JL, Shen DH, Chen YX and Song
QJ: Morphologic changes of fallopian tubal epithelium in ovarian
serous tumors. Zhonghua Bing Li Xue Za Zhi. 41:433–437. 2012.(In
Chinese). PubMed/NCBI
|
|
4
|
Li J, Ning Y, Abushahin N, Yuan Z, Wang Y,
Wang Y, Yuan B, Cragun JM, Chambers SK, Hatch K, et al: Secretory
cell expansion with aging: Risk for pelvic serous carcinogenesis.
Gynecol Oncol. 131:555–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen EY, Mehra K, Mehrad M, Ning G, Miron
A, Mutter GL, Monte N, Quade BJ, McKeon FD, Yassin Y, et al:
Secretory cell outgrowth, PAX2 and serous carcinogenesis in the
Fallopian tube. J Pathol. 222:110–116. 2010.PubMed/NCBI
|
|
6
|
Carlson JW, Miron A, Jarboe EA, Parast MM,
Hirsch MS, Lee Y, Muto MG, Kindelberger D and Crum CP: Serous tubal
intraepithelial carcinoma: Its potential role in primary peritoneal
serous carcinoma and serous cancer prevention. J Clin Oncol.
26:4160–4165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carcangiu ML, Radice P, Manoukian S,
Spatti G, Gobbo M, Pensotti V, Crucianelli R and Pasini B: Atypical
epithelial proliferation in fallopian tubes in prophylactic
salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline
mutation carriers. Int J Gynecol Pathol. 23:35–40. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leunen K, Legius E, Moerman P, Amant F,
Neven P and Vergote I: Prophylactic salpingo-oophorectomy in 51
women with familial breast-ovarian cancer: Importance of fallopian
tube dysplasia. Int J Gynecol Cancer. 16:183–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piek JM, van Diest PJ, Zweemer RP, Jansen
JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G,
Kenemans P and Verheijen RH: Dysplastic changes in prophylactically
removed Fallopian tubes of women predisposed to developing ovarian
cancer. J Pathol. 195:451–456. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crum CP, Drapkin R, Miron A, Ince TA, Muto
M, Kindelberger DW and Lee Y: The distal fallopian tube: A new
model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol.
19:3–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jarboe EA, Folkins AK, Drapkin R, Ince TA,
Agoston ES and Crum CP: Tubal and ovarian pathways to pelvic
epithelial cancer: A pathological perspective. Histopathology.
53:127–138. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mittal N, Srinivasan R, Gupta N, Rajwanshi
A, Nijhawan R, Gautam U, Sood S and Dhaliwal L: Secretory cell
outgrowths, p53 signatures, and serous tubal intraepithelial
carcinoma in the fallopian tubes of patients with sporadic pelvic
serous carcinoma. Indian J Pathol Microbiol. 59:481–488. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li HX, Lu ZH, Shen K, Cheng WJ, Malpica A,
Zhang J, Wei JJ, Zhang ZH and Liu J: Advances in serous tubal
intraepithelial carcinoma: correlation with high grade serous
carcinoma and ovarian carcinogenesis. Int J Clin Exp Pathol.
7:848–857. 2014.PubMed/NCBI
|
|
14
|
Ebihara T, Yoshimura Y, Shiraki M,
Maruyama K, Ichikawa F, Kawakami S, Fukushima M and Oda T: Role of
endosalpinx in the oviductal environment. Nihon Sanka Fujinka
Gakkai Zasshi. 41:881–887. 1989.(In Japanese). PubMed/NCBI
|
|
15
|
Piek JM, van Diest PJ, Verheijen RH and
Kenemans P: Cell cycle-related proteins p21 and bcl-2: Markers of
differentiation in the human fallopian tube. Histopathology.
38:481–482. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamamoto Y, Ning G, Howitt BE, Mehra K, Wu
L, Wang X, Hong Y, Kern F, Wei TS, Zhang T, et al: In vitro and in
vivo correlates of physiological and neoplastic human Fallopian
tube stem cells. J Pathol. 238:519–530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang HS, Hsu CF, Chu SC, Chen PC, Ding
DC, Chang MY and Chu TY: Haemoglobin in pelvic fluid rescues
Fallopian tube epithelial cells from reactive oxygen species stress
and apoptosis. J Pathol. 240:484–494. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vang R, Visvanathan K, Gross A, Maambo E,
Gupta M, Kuhn E, Li RF, Ronnett BM, Seidman JD, Yemelyanova A, et
al: Validation of an algorithm for the diagnosis of serous tubal
intraepithelial carcinoma. Int J Gynecol Pathol. 31:243–253. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weinberger V, Bednarikova M, Cibula D and
Zikan M: Serous tubal intraepithelial carcinoma (STIC) - clinical
impact and management. Expert Rev Anticancer Ther. 16:1311–1321.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen F, Gaitskell K, Garcia MJ, Albukhari
A, Tsaltas J and Ahmed AA: Serous tubal intraepithelial carcinomas
associated with high-grade serous ovarian carcinomas: A systematic
review. BJOG. 124:872–878. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schneider S, Heikaus S, Harter P, Heitz F,
Grimm C, Ataseven B, Prader S, Kurzeder C, Ebel T, Traut A and du
Bois A: Serous tubal intraepithelial carcinoma associated with
extraovarian metastases. Int J Gynecol Cancer. 27:444–451. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malmberg K, Klynning C, Flöter-Rådestad A
and Carlson JW: Serous tubal intraepithelial carcinoma, chronic
fallopian tube injury, and serous carcinoma development. Virchows
Arch. 468:707–713. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Corzo C, Iniesta MD, Patrono MG, Lu KH and
Ramirez PT: Role of fallopian tubes in the development of ovarian
cancer. J Minim Invasive Gynecol. 24:230–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eckert MA, Pan S, Hernandez KM, Loth RM,
Andrade J, Volchenboum SL, Faber P, Montag A, Lastra R, Peter ME,
et al: Genomics of ovarian cancer progression reveals diverse
metastatic trajectories including intraepithelial metastasis to the
fallopian tube. Cancer Discov. 6:1342–1351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ning G, Bijron JG, Yamamoto Y, Wang X,
Howitt BE, Herfs M, Yang E, Hong Y, Cornille M, Wu L, et al: The
PAX2-null immunophenotype defines multiple lineages with common
expression signatures in benign and neoplastic oviductal
epithelium. J Pathol. 234:478–487. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Comer MT, Leese HJ and Southgate J:
Induction of a differentiated ciliated cell phenotype in primary
cultures of Fallopian tube epithelium. Hum Reprod. 13:3114–3120.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adler E, Mhawech-Fauceglia P, Gayther SA
and Lawrenson K: PAX8 expression in ovarian surface epithelial
cells. Hum Pathol. 46:948–956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Banet N and Kurman RJ: Two types of
ovarian cortical inclusion cysts: Proposed origin and possible role
in ovarian serous carcinogenesis. Int J Gynecol Pathol. 34:3–8.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karst AM, Levanon K, Duraisamy S, Liu JF,
Hirsch MS, Hecht JL and Drapkin R: Stathmin 1, a marker of PI3K
pathway activation and regulator of microtubule dynamics, is
expressed in early pelvic serous carcinomas. Gynecol Oncol.
123:5–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bajwa P, Nagendra PB, Nielsen S, Sahoo SS,
Bielanowicz A, Lombard JM, Wilkinson JE, Miller RA and Tanwar PS:
Age related increase in mTOR activity contributes to the
pathological changes in ovarian surface epithelium. Oncotarget.
7:19214–19227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chui MH, Wang Y, Wu RC, Seidman J, Kurman
RJ, Wang TL and Shih IeM: Loss of ALDH1A1 expression is an early
event in the pathogenesis of ovarian high-grade serous carcinoma.
Mod Pathol. 28:437–445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuhn E, Wang TL, Doberstein K,
Bahadirli-Talbott A, Ayhan A, Sehdev AS, Drapkin R, Kurman RJ and
Shih IeM: CCNE1 amplification and centrosome number abnormality in
serous tubal intraepithelial carcinoma: Further evidence supporting
its role as a precursor of ovarian high-grade serous carcinoma. Mod
Pathol. 29:1254–1261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Novak M, Lester J, Karst AM, Parkash V,
Hirsch MS, Crum CP, Karlan BY and Drapkin R: Stathmin 1 and p16
(INK4A) are sensitive adjunct biomarkers for serous tubal
intraepithelial carcinoma. Gynecol Oncol. 139:104–111. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kuhn E, Kurman RJ, Soslow RA, Han G,
Sehdev AS, Morin PJ, Wang TL and Shih IeM: The diagnostic and
biological implications of laminin expression in serous tubal
intraepithelial carcinoma. Am J Surg Pathol. 36:1826–1834. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuhn E, Meeker A, Wang TL, Sehdev AS,
Kurman RJ and Shih IeM: Shortened telomeres in serous tubal
intraepithelial carcinoma: An early event in ovarian high-grade
serous carcinogenesis. Am J Surg Pathol. 34:829–836. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sehdev AS, Kurman RJ, Kuhn E and Shih IeM:
Serous tubal intraepithelial carcinoma upregulates markers
associated with high-grade serous carcinomas including Rsf-1
(HBXAP), cyclin E and fatty acid synthase. Mod Pathol. 23:844–855.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wei JJ, Wu J, Luan C, Yeldandi A, Lee P,
Keh P and Liu J: HMGA2: A potential biomarker complement to P53 for
detection of early-stage high-grade papillary serous carcinoma in
fallopian tubes. Am J Surg Pathol. 34:18–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fathalla MF: Incessant ovulation - -a
factor in ovarian neoplasia? Lancet. 2:1631971. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Merritt MA and Cramer DW: Molecular
pathogenesis of endometrial and ovarian cancer. Cancer Biomark.
9:287–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kurman RJ: Origin and molecular
pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol.
24:x16–x21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meserve EEK, Brouwer J and Crum CP: Serous
tubal intraepithelial neoplasia: The concept and its application.
Mod Pathol. 30:710–721. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gilks CB, Irving J, Köbel M, Lee C, Singh
N, Wilkinson N and McCluggage WG: Incidental nonuterine high-grade
serous carcinomas arise in the fallopian tube in most cases:
Further evidence for the tubal origin of high-grade serous
carcinomas. Am J Surg Pathol. 39:357–364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Crum CP, Herfs M, Ning G, Bijron JG,
Howitt BE, Jimenez CA, Hanamornroongruang S, McKeon FD and Xian W:
Through the glass darkly: Intraepithelial neoplasia, top-down
differentiation, and the road to ovarian cancer. J Pathol.
231:402–412. 2013. View Article : Google Scholar : PubMed/NCBI
|
